Teplizumab Induces Human Gut-Tropic Regulatory Cells in Humanized Mice and Patients
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Humanized mice can be successfully used as a preclinical testing platform to identify the mechanism of action of immunotherapies in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Self-citationInsulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Sherry, N., Hagopian, W., Ludvigsson, J., Jain, S. M., Wahlen, J., Ferry, R. J., Bode, B., Aronoff, S., Holland, C., Carlin, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60931-8 · Cited by 493
Self-citationHerold, K. C., Gitelman, S., Greenbaum, C., Puck, J., Hagopian, W., Gottlieb, P., Sayre, P., Bianchine, P., Wong, E., Seyfert-Margolis, V., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.04.007 · Cited by 219
Self-citation
Research works printed but not linked: 32
- 10.4049/jimmunol.1090051 · DOI · Paper page
- 10.7326/0003-4819-144-12-200606200-00003 · DOI · Paper page
- 10.1056/NEJMoa044397 · DOI · Paper page
- 10.1056/NEJMoa011110 · DOI · Paper page
- 10.1038/nri2705 · DOI
- 10.1038/nrd3402 · DOI
- 10.1002/eji.200939429 · DOI
- Chatenoud L., Primo J., Bach J. F., CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158, 2947–2954 (1997). · DOI · Paper page
- 10.1073/pnas.91.1.123 · DOI · Paper page
- 10.1038/nri2134 · DOI · Paper page
- Hirsch R., Gress R. E., Pluznik D. H., Eckhaus M., Bluestone J. A., Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J. Immunol. 142, 737–743 (1989). · DOI · Paper page
- 10.2337/diabetes.54.6.1763 · DOI · Paper page
- 10.1172/JCI16090 · DOI · Paper page
- 10.1016/j.humimm.2009.06.005 · DOI · Paper page
- 10.1016/j.clim.2011.02.019 · DOI
- 10.1097/TP.0b013e3181a5cb07 · doi:10.1097/tp.0b013e3181a5cb07
- 10.1073/pnas.1005566107 · DOI · Paper page
- 10.1016/j.chom.2010.09.003 · DOI · Paper page
- 10.4049/jimmunol.1100394 · DOI
- 10.1111/j.1365-2567.2011.03501.x · DOI
- 10.4049/jimmunol.0803418 · DOI · Paper page
- 10.1097/01.mpg.0000252191.05170.e7 · doi:10.1097/01.mpg.0000252191.05170.e7
- 10.1016/S0002-9440(10)61738-5 · DOI
- 10.4049/jimmunol.1100713 · DOI · Paper page
- 10.1023/B:JOCI.0000018066.46279.6b · DOI · Paper page
- 10.1128/IAI.01660-06 · DOI
- 10.1152/ajpgi.00089.2010 · DOI
- 10.1038/nature10228 · DOI · Paper page
- 10.1097/00007890-199909150-00003 · DOI · Paper page
- 10.1093/bioinformatics/btg157 · DOI · Paper page
- Codorean E., Nichita C., Albulescu L., RÄducan E., Popescu I. D., LonitÄ A. C., Albulescu R., Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro. Roum. Arch. Microbiol. Immunol. 69, 13–19 (2010).
- Garrod K. R., Cahalan M. D., Murine skin transplantation. J. Vis. Exp. 11, 634 (2008).
Cited by
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902226 · Cited by 1,189
Self-citationHumanized mice for immune system investigation: progress, promise and challenges
Shultz, L. D., Brehm, M. A., Garcia-Martinez, J. V., & Greiner, D. L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3311 · Cited by 979
Herold, K. C., Gitelman, S. E., Ehlers, M. R., Gottlieb, P. A., Greenbaum, C. J., Hagopian, W., Boyle, K. D., Keyes-Elstein, L., Aggarwal, S., Phippard, D., et al. (2013) · Diabetes · doi:10.2337/db13-0345 · Cited by 411
Self-citationHumanized mice in studying efficacy and mechanisms of PD‐1‐targeted cancer immunotherapy
Wang, M., Yao, L., Cheng, M., Cai, D., Martinek, J., Pan, C., Shi, W., Ma, A., de Vere White, R. W., Airhart, S., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700740r · Cited by 339
The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes
Pearson, J. A., Wong, F. S., & Wen, L. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.019 · Cited by 298
Metadata
- Authors
- Waldron-Lynch, F., Henegariu, O., Deng, S., Preston-Hurlburt, P., Tooley, J., Flavell, R., & Herold, K. C.
- Venue
- Science Translational Medicine
- Published
- 2012-01-25
- Volume
- 4
- Issue
- 118
- Pages
- 118ra12-118ra12
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2125970797
- Cited by
- 94
- References
- 5
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.